ScholarIQanswers from OpenAlex

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study

PaperCitations, authors & open-access status

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study have?

ScholarIQcitation count

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study has 850 citations in the OpenAlex counts ScholarIQ stores.

When was Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study published?

ScholarIQyear

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study has 2021 year in the ScholarIQ index.

What is the open-access status of Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study?

ScholarIQoa status

Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study has closed oa status in the ScholarIQ index.

What is the DOI of Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study?

ScholarIQdoi

The DOI for Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study is on the source record.

What is the PMID of Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study?

ScholarIQpmid

The PMID for Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study is on the source record.

What is the OpenAlex record for Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study?

ScholarIQopenalex

The OpenAlex for Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial